{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:53Z","timestamp":1791920933589,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.vaccine.2003.05.002","type":"journal-article","created":{"date-parts":[[2003,10,16]],"date-time":"2003-10-16T15:12:33Z","timestamp":1066317153000},"page":"1063-1071","source":"Crossref","is-referenced-by-count":35,"title":["A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome\u2122) protects guinea pigs from lethal tuberculosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Mark A","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.Craig","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Brisker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Gavier-Wid\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Glyn","family":"Hewinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.05.002_BIB1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S0950268800067686","article-title":"Bovine tubercle bacilli and disease in animals and man","volume":"99","author":"Grange","year":"1987","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB2","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1073\/pnas.91.6.2091","article-title":"Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy","volume":"91","author":"Salo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0764-4469(99)80009-2","article-title":"Identification of Mycobacterium DNA in an Egyptian Pott\u2019s disease of 5400 years old","volume":"321","author":"Crubezy","year":"1998","journal-title":"C. R. Acad. Sci. III"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00005792-199301000-00002","article-title":"Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen","volume":"72","author":"Dankner","year":"1993","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2003.05.002_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0962-8479(95)90591-X","article-title":"The epidemiology of Mycobacterium bovis infections in animals and man: a review","volume":"76","author":"O\u2019Reilly","year":"1995","journal-title":"Tuberc. Lung Dis."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB6","unstructured":"Steele JH. Regional and country status reports\u2014introduction. In: Thoen CO, Steele JH, editors. Mycobacterium bovis infection in animals and humans. Ames, IA: University Press; 1995. p. 47\u201361."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB7","unstructured":"Krebs JR. Bovine tuberculosis in cattle and badgers. London, UK: Ministry of Agriculture, Fisheries and Food Publications, London; 1997."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB8","doi-asserted-by":"crossref","unstructured":"Bloom BR, Fine PEM. The BCG experience: implications for future vaccines against tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenicity, protection, and control. Washington: American Society for Microbiology; 1994. p. 531\u201357.","DOI":"10.1128\/9781555818357.ch31"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB10","unstructured":"Anonymous. Trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 198072 (Suppl) 1\u201374."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB11","unstructured":"Williams DE. Mycobacterium bovis BCG infection in humans. In: Thoen CO, Steele JH, editors. Mycobacterium bovis infection in animals and humans. Ames, IA: University Press; 1995. p. 47\u201361."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-842X(00)01949-1","article-title":"Tuberculosis vaccine development: recent progress","volume":"9","author":"Orme","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0264-410X(99)00540-X","article-title":"The immunogenicity of single and combination DNA vaccines against tuberculosis","volume":"18","author":"Morris","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1440-1711.2000.00937.x","article-title":"New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex","volume":"78","author":"Collins","year":"2000","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB16","first-page":"228","article-title":"Viability and multiplication of vaccines in immunization against tuberculosis","volume":"71","author":"Bloch","year":"1955","journal-title":"Am. Rev. Tuberc. Pulm. Dis."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB17","unstructured":"Youmans GP. Acquired immunity in tuberculosis. In: Youmans GP, editor. Tuberculosis. London: Saunders; 1979. p. 225\u201335."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB18","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/IAI.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB19","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/IAI.65.5.1856-1862.1997","article-title":"Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae","volume":"65","author":"Abou-Zeid","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB20","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/IAI.59.4.1558-1563.1991","article-title":"T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis","volume":"59","author":"Andersen","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/MMBR.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1064571","article-title":"Priming of memory but not effector CD8 T cells by a killed bacterial vaccine","volume":"294","author":"Lauvau","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0140-6736(01)25559-7","article-title":"Note on the treatment of tuberculosis","volume":"1","author":"Spahlinger","year":"1922","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1139\/cjr49e-008","article-title":"Protection by killed vole bacillus vaccine against experimental tuberculosis in guinea pigs","volume":"27","author":"Paterson","year":"1949","journal-title":"Can. J. Res."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(91)90309-T","article-title":"Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w","volume":"9","author":"Singh","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB26","first-page":"242","article-title":"Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv","volume":"99","author":"Anacker","year":"1969","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000237172","article-title":"Vaccination against tuberculosis","volume":"108","author":"Lowrie","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.97.2.221","article-title":"Antituberculous immunity in mice vaccinated with killed tubercle bacilli","volume":"97","author":"Dubos","year":"1953","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1699-0463.1998.tb01361.x","article-title":"Evaluation of an immunohistochemical test with polyclonal antibodies raised against mycobacteria used in formalin-fixed tissue compared with mycobacterial specific culture","volume":"106","author":"Carabias","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0264-410X(95)00182-Z","article-title":"Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens","volume":"14","author":"Gupta","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/aid.1998.14.741","article-title":"Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17","volume":"14","author":"Zimmerman","year":"1998","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0076-6879(91)04027-L","article-title":"Genetic systems for mycobacteria","volume":"204","author":"Jacobs","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/00222615-42-6-433","article-title":"Experimental Legionnaires\u2019 disease in SCID-Beige mice reconstituted with human leucocytes","volume":"42","author":"Williams","year":"1995","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-1135(00)00378-3","article-title":"A guinea pig model of low-dose Mycobacterium bovis aerogenic infection","volume":"80","author":"Chambers","year":"2001","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/IAI.56.3.682-686.1988","article-title":"Liposomes, lipid A and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen","volume":"56","author":"Richards","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0923-2494(92)80165-H","article-title":"Liposomes containing lipid A as a potent non-toxic adjuvant","volume":"143","author":"Alving","year":"1992","journal-title":"Res. Immunol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB37","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","article-title":"ESAT-6 subunit vaccination against Mycobacterium tuberculosis","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB39","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1128\/IAI.68.10.5809-5815.2000","article-title":"Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis","volume":"68","author":"Wedlock","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB40","doi-asserted-by":"crossref","unstructured":"Heilbron IM, Owens WM. The unsaponifiable matter from the oils of elasmobranch fish. Part IV. The establishment of the structure of selachyl and batyl alcohols as monoglyceryl ethers. J Chem Soc 1928;942\u20137.","DOI":"10.1039\/JR9280000942"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB41","first-page":"6044","article-title":"Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues","volume":"48","author":"Yamamoto","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB42","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/IAI.68.12.7094-7099.2000","article-title":"Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin","volume":"68","author":"Chambers","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB43","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1128\/IAI.70.4.2159-2165.2002","article-title":"Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis","volume":"70","author":"Chambers","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB44","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Weinrich Olsen","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB45","first-page":"483","article-title":"What\u2019s new in tuberculosis vaccines?","volume":"80","author":"Ginsberg","year":"2002","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2307\/4586032","article-title":"A comparative study of live and killed vaccines in experimental tuberculosis","volume":"62","author":"Olson","year":"1947","journal-title":"Public Health Rep."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB47","first-page":"418","article-title":"Immunization studies with irradiated tuberculosis vaccines","volume":"62","author":"Sarber","year":"1950","journal-title":"Am. Rev. Tuberc."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3181\/00379727-75-18323","article-title":"Immunization of mice with ultraviolet killed tuberculosis vaccines","volume":"75","author":"Milzer","year":"1950","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB49","first-page":"341","article-title":"Irradiated antituberculosis vaccine, including comparison with BCG in experimentally infected guinea pigs","volume":"67","author":"Seagle","year":"1952","journal-title":"Am. Rev. Tuberc."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.176.2.581","article-title":"Evidence for an alpha\/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells","volume":"176","author":"Izzo","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB51","first-page":"183","article-title":"Macrophage recognition of self from nonself: implications for the interaction of macrophages with neoplastic cells","volume":"38","author":"Fidler","year":"1986","journal-title":"Symp. Fundam. Cancer Res."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0264-410X(88)90177-6","article-title":"Potency testing of BCG vaccines on white mice: influence of variables on survival time, lung findings and vaccine assessment","volume":"6","author":"Freudenstein","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB53","doi-asserted-by":"crossref","unstructured":"Rook GAW, Bloom BR. Mechanisms of pathogenesis in tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington, DC: American Society for Microbiology; 1994. p. 485\u2013501.","DOI":"10.1128\/9781555818357.ch28"},{"key":"10.1016\/j.vaccine.2003.05.002_BIB54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/IAI.24.2.363-370.1979","article-title":"Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis","volume":"24","author":"Wayne","year":"1979","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB55","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/IAI.59.6.1905-1910.1991","article-title":"Proteins released from Mycobacterium tuberculosis during growth","volume":"59","author":"Andersen","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2672.2000.01020.x","article-title":"The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium","volume":"88","author":"James","year":"2000","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.vaccine.2003.05.002_BIB57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-1656(02)00046-9","article-title":"Cultivation of Mycobacterium bovis BCG in bioreactors","volume":"96","author":"Dietrich","year":"2002","journal-title":"J. Biotechnol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T04:08:55Z","timestamp":1585195735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0264410X03006674"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.05.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}